Literature DB >> 6247241

A new filamentous phage cloning vector: fd-tet.

A N Zacher, C A Stock, J W Golden, G P Smith.   

Abstract

We have constructed a hybrid chromosome composed of the genome of wild-type fd (a filamentous, male-specific bacteriophage) and a segment of transposon Tn10 coding for tetracycline resistance but not including the Tn10 insertion sequences. The hybrid phage infects male E. coli, thereby transducing the infected cells to tetracycline resistance. The phage DNA can also be propagated in F- cells after transfection. This new phage, fd-tet, may be used as a cloning vector to produce large quantities of cloned DNA in single-stranded form. Its usefulness has been demonstrated by cloning of a fragment from bacteriophage lambda. Some unexpected sequence alterations have been identified in lambda cloning experiments.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6247241     DOI: 10.1016/0378-1119(80)90171-7

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  36 in total

1.  Identifying diagnostic peptides for lyme disease through epitope discovery.

Authors:  G A Kouzmitcheva; V A Petrenko; G P Smith
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

2.  The rational design of a 'type 88' genetically stable peptide display vector in the filamentous bacteriophage fd.

Authors:  D Enshell-Seijffers; L Smelyanski; J M Gershoni
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

3.  Selection of peptide ligands for the antimucin core antibody C595 using phage display technology: definition of candidate epitopes for a cancer vaccine.

Authors:  P Laing; P Tighe; E Kwiatkowski; J Milligan; M Price; H Sewell
Journal:  Clin Mol Pathol       Date:  1995-06

4.  Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains.

Authors:  H R Hoogenboom; A D Griffiths; K S Johnson; D J Chiswell; P Hudson; G Winter
Journal:  Nucleic Acids Res       Date:  1991-08-11       Impact factor: 16.971

5.  Human papillomavirus type 18 E6 and E7 antibodies in human sera: increased anti-E7 prevalence in cervical cancer patients.

Authors:  C Bleul; M Müller; R Frank; H Gausepohl; U Koldovsky; H N Mgaya; J Luande; M Pawlita; J ter Meulen; R Viscidi
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

Review 6.  Progress in phage display: evolution of the technique and its application.

Authors:  Tomaz Bratkovic
Journal:  Cell Mol Life Sci       Date:  2010-03       Impact factor: 9.261

7.  Peptides isolated from random peptide libraries on phage elicit a neutralizing anti-HIV-1 response: analysis of immunological mimicry.

Authors:  K Lundin; A Samuelsson; M Jansson; J Hinkula; B Wahren; H Wigzell; M A Persson
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

8.  Hybridoma-free generation of monoclonal antibodies.

Authors:  Renata Pasqualini; Wadih Arap
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-19       Impact factor: 11.205

9.  A novel peptide (GX1) homing to gastric cancer vasculature inhibits angiogenesis and cooperates with TNF alpha in anti-tumor therapy.

Authors:  Bei Chen; Shanshan Cao; Yingqi Zhang; Xin Wang; Jie Liu; Xiaoli Hui; Yi Wan; Wenqi Du; Li Wang; Kaichun Wu; Daiming Fan
Journal:  BMC Cell Biol       Date:  2009-09-09       Impact factor: 4.241

10.  Identification of peptide ligands for targeting to the blood-brain barrier.

Authors:  Inge van Rooy; Serpil Cakir-Tascioglu; Pierre-Olivier Couraud; Ignacio A Romero; Babette Weksler; Gert Storm; Wim E Hennink; Raymond M Schiffelers; Enrico Mastrobattista
Journal:  Pharm Res       Date:  2010-02-17       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.